SCHEMBL6741340

SCHEMBL6741340

CC1CCCC(CN(C)C)C1=O

nearest known ligand 0.38

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
METAP1 P53582 4/20 0.35
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA4 P22748 1/20 0.34
CCR6 P51684 1/20 0.34
KMT2A Q03164 1/20 0.33
HTR6 P50406 1/20 0.32
MITF O75030 1/20 0.32
HSP90AA1 P07900 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5997701 0.87 METAP1 (0.39) METAP1CCR6MITFHSP90AA1
Hydrochloric Acid SCHEMBL29441540 0.85 METAP1 (0.41) METAP1CCR6MITFHSP90AA1
SCHEMBL12721211 0.81 METAP1 (0.38) METAP1CCR6MITFHSP90AA1
SCHEMBL3965498 0.78 METAP1 (0.41) METAP1CCR6MITFHSP90AA1
SCHEMBL10710085 0.77 CA1 (0.38) CA1CA2CA4KMT2A
SCHEMBL6906976 0.75 CA1 (0.37) CA1CA2CA4KMT2A
SCHEMBL23747126 0.74 LMNA (0.40) KMT2A
SCHEMBL18588301 0.72
SCHEMBL6903125 0.72
SCHEMBL83778 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1322593-B1 O-SUBSTITUTED 6-METHYL-TRAMADOL DERIVATIVES GRUENENTHAL GMBH (DE) 2004-07-28 EP claimed
CN-1478067-A O-substituted 6-methyl-tramadol derivatives 2004-02-25 CN claimed
EP-1322593-A1 O-SUBSTITUTED 6-METHYL-TRAMADOL DERIVATIVES Grünenthal GmbH (DE) 2003-07-02 EP claimed
WO-2002026694-A1 O-SUBSTITUTED 6-METHYL-TRAMADOL DERIVATIVES Grünenthal GmbH (DE) 2002-04-04 WO claimed
US-6828345-B2 Tertiary amines such as 2-dimethylaminomethyl-1-(3-methoxy-phenyl)-6-methylcyclohexanol, used as analgesics GRUENENTHAL GMBH (DE) 2004-12-07 US disclosed
EP-1322593-B1 O-SUBSTITUTED 6-METHYL-TRAMADOL DERIVATIVES GRUENENTHAL GMBH (DE) 2004-07-28 EP disclosed
CN-1478067-A O-substituted 6-methyl-tramadol derivatives 2004-02-25 CN disclosed
US-20030220389-A1 O-substituted 6-methyltramadol derivatives GRUENENTHAL GMBH (DE) 2003-11-27 US disclosed
EP-1322593-A1 O-SUBSTITUTED 6-METHYL-TRAMADOL DERIVATIVES Grünenthal GmbH (DE) 2003-07-02 EP disclosed
WO-2002026694-A1 O-SUBSTITUTED 6-METHYL-TRAMADOL DERIVATIVES Grünenthal GmbH (DE) 2002-04-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030220389-A1 O-substituted 6-methyltramadol derivatives OPRK1, TPMT, OPRM1 METAP1 920/4885CA1 4499/4885CA2 2861/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.